1. Anholt RRH. 1986. Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolism. TiPS 7: 506–511.
2. Arauja DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. 1988. Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50: 1914–1923.
3. Bachmann C, Colombo JP. 1984. Increase of tryptophan and 5-hydroxyindoleacetic acid in the brain of ornithine carbamoyl transferase deficient sparse-fur mice. Pediatr Res 18: 372–375.
4. Bakker MHM, Foster AC. 1991. An investigation of the mechanisms of delayed neuron degeneration caused by direct injection of quinolinic acid into the rat striatum in vivo. Neuroscience 42: 387–395.
5. Bassi S, Ferrarese C, Finola MG, Frattola L, Lannucelli M, et al. 1988. L-Acetyl-carnitine in Alzheimer disease (AD) and Senile Dementia of the Alzheimer type (SDAT). Senile Dementias (Second International Symposium). Agnoli A, Cahn J, Larsen N, Mayeux R, editors. Paris: John Libbey Eurotext; pp. 461–466.